Metformin vs Osimertinib
Metformin vs Osimertinib: Overview
This comparison examines the pharmacological differences between Metformin and Osimertinib.
Mechanism of Action
Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Pharmacokinetics
Half-life: Metformin β 4-9 hours; Osimertinib β 48 hours.
Chemical Properties
Molecular Formula: Metformin β C4H11N5; Osimertinib β C28H33N7O2.
Molecular Weight: Metformin β 129.1640 g/mol; Osimertinib β 499.6050 g/mol.
Type: Metformin β Small molecule; Osimertinib β Small molecule.